Hatchtech Pty Ltd to explore strategic alternatives for commercialization of Xeglyze™ lotion in the U.S.

chevron_leftPreviosly
OneVentures appoints new Venture Partner
07 May 2015
Nextchevron_right
Vaxxas Nanopatch on Channel 7 News and Today Tonight
23 February 2015

You may also like

11 April 2013

OneVentures team ‘charmed’ by Queensland Health-IT company

07 October 2021

Blade Therapeutics Announces Publication of Preclinical Evidence Supporting Neuroprotective Effects of Proprietary Calpain Inhibitor in a Rare Inherited Neurodegenerative Disease

26 August 2014

Vaxxas Selected as World Economic Forum Technology Pioneer 2015

Awards, Media Release

17 December 2015

OneVentures’ Innovation and Growth Fund II hits $100 million in FUM

24 March 2014

charmhealth names Gary Lakin as new CEO

30 April 2020

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor